These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 22051568)

  • 1. A mathematical model of tumor-immune interactions.
    Robertson-Tessi M; El-Kareh A; Goriely A
    J Theor Biol; 2012 Feb; 294():56-73. PubMed ID: 22051568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of immune evasion by gliomas.
    Rolle CE; Sengupta S; Lesniak MS
    Adv Exp Med Biol; 2012; 746():53-76. PubMed ID: 22639159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppressive strategies that are mediated by tumor cells.
    Rabinovich GA; Gabrilovich D; Sotomayor EM
    Annu Rev Immunol; 2007; 25():267-96. PubMed ID: 17134371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated human CD4+ T cells induced by dendritic cell stimulation are most sensitive to transforming growth factor-beta: implications for dendritic cell immunization against cancer.
    Lin CM; Wang FH; Lee PK
    Clin Immunol; 2002 Jan; 102(1):96-105. PubMed ID: 11781072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosuppressive dendritic and regulatory T cells are upregulated in melanoma patients.
    McCarter MD; Baumgartner J; Escobar GA; Richter D; Lewis K; Robinson W; Wilson C; Palmer BE; Gonzalez R
    Ann Surg Oncol; 2007 Oct; 14(10):2854-60. PubMed ID: 17593331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory T cell: a protection for tumour cells.
    Wang Y; Ma Y; Fang Y; Wu S; Liu L; Fu D; Shen X
    J Cell Mol Med; 2012 Mar; 16(3):425-36. PubMed ID: 21895966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breaking immunotolerance of tumors: a new perspective for dendritic cell therapy.
    Rolinski J; Hus I
    J Immunotoxicol; 2014 Oct; 11(4):311-8. PubMed ID: 24495309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
    da Cunha A; Antoniazi Michelin M; Cândido Murta EF
    Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of tumor escape from immune system: role of mesenchymal stromal cells.
    Poggi A; Musso A; Dapino I; Zocchi MR
    Immunol Lett; 2014; 159(1-2):55-72. PubMed ID: 24657523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status of interleukin-10 and regulatory T-cells in cancer.
    Dennis KL; Blatner NR; Gounari F; Khazaie K
    Curr Opin Oncol; 2013 Nov; 25(6):637-45. PubMed ID: 24076584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How regulatory CD25(+)CD4(+) T cells impinge on tumor immunobiology? On the existence of two alternative dynamical classes of tumors.
    Leon K; Garcia K; Carneiro J; Lage A
    J Theor Biol; 2007 Jul; 247(1):122-37. PubMed ID: 17412365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immune system and tumors].
    Terme M; Tanchot C
    Ann Pathol; 2017 Feb; 37(1):11-17. PubMed ID: 28159405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of tumor escape from the immune system: adenosine-producing Treg, exosomes and tumor-associated TLRs.
    Whiteside TL; Mandapathil M; Szczepanski M; Szajnik M
    Bull Cancer; 2011 Feb; 98(2):E25-31. PubMed ID: 21339097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of immune inhibitory dendritic cells and CD4+T regulatory cells inducing by TGF-beta.
    Abediankenari S; Ghasemi M
    Iran J Allergy Asthma Immunol; 2009 Mar; 8(1):25-30. PubMed ID: 19279356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple roles for CD4+ T cells in anti-tumor immune responses.
    Kennedy R; Celis E
    Immunol Rev; 2008 Apr; 222():129-44. PubMed ID: 18363998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of human allergic T-helper type 2 immune responses by induced regulatory T cells requires the combination of interleukin-10-treated dendritic cells and transforming growth factor-beta for their induction.
    Bellinghausen I; König B; Böttcher I; Knop J; Saloga J
    Clin Exp Allergy; 2006 Dec; 36(12):1546-55. PubMed ID: 17177678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of TGF-beta signaling in dendritic cell tolerance.
    Esebanmen GE; Langridge WHR
    Immunol Res; 2017 Oct; 65(5):987-994. PubMed ID: 28845509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory T-cell immunity and its relevance to atherosclerosis.
    Taleb S; Tedgui A; Mallat Z
    J Intern Med; 2008 May; 263(5):489-99. PubMed ID: 18410592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of tolerance induced by transforming growth factor-beta-treated antigen-presenting cells: CD8 regulatory T cells inhibit the effector phase of the immune response in primed mice through a mechanism involving Fas ligand.
    Kosiewicz MM; Alard P; Liang S; Clark SL
    Int Immunol; 2004 May; 16(5):697-706. PubMed ID: 15096489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cancer immunotherapy. Importance of overcoming immune suppression].
    Malvicini M; Puchulo G; Matar P; Mazzolini G
    Medicina (B Aires); 2010; 70(6):565-70. PubMed ID: 21163748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.